Inventia

formerly Inventia Life Sciences

Inventia is a biotech company in Sydney, Australia, founded in 2017. It has raised $70.1M across 4 rounds, most recently a $3.5M Extension Round in April 2025.

Inventia Life Science | Scalable 3D Cell Models for Research

Employees
11–50
Founded
2017
Business Model
B2B
Total Funding
$70.1M
Last Round
$3.5M Extension RoundApr 2025
Rounds
4

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 4 funding rounds and 5 investors for this company. The full record is or through the API.

About

Inventia Life Science is a Sydney, Australia-based biotech company and pioneer in 3D cell culture technology. Its RASTRUM platform uses drop-on-demand bioprinting and xeno-free tunable matrices to generate reproducible, biologically relevant 3D cell models for cancer research, drug discovery, and personalized medicine, complemented by Discovery Services for phenotypic drug discovery programs. The company has expanded internationally, opening a U.S. location in 2022.

Summary

It lists 11–50 employees. It has raised $70.1M in total across 4 rounds, most recently a $3.5M Extension Round in Apr 2025. Investors include Sonder Capital, Blackbird Ventures and Skip Capital.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
Extension RoundExtension RoundApr 2025
$3.5M

Sign up to see all 4 events

Funding: Seed through Extension Round. Amounts, valuations, and investors where available.

Investors

Similar Companies

Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
BridgeBioIPO

BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...

San Francisco Bay Area, United States201–500Biotech, Healthcare
Growth EquityTotal funding$2.7BJul 2026
AsymchemIPO

Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...

Tianjin, China5001–10000Biotech, Drug Discovery
Private EquityTotal funding$2.3BFeb 2020
Calico

Calico researches human aging using advanced technologies and model systems, applying that knowle...

South San Francisco, United States201–500Biotech, Healthcare
Corporate RoundTotal funding$2.3BJun 2018
Sana BiotechnologyIPO

Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...

Seattle, United States201–500Biotech, Healthcare
Series DTotal funding$1.4BJun 2020
CertaraIPO

Global biosimulation software and services company accelerating drug development for 2,000+ bioph...

Radnor, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$1.3BDec 2022

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Inventia on Indexed.vc
<a href="https://indexed.vc/companies/inventia"><img src="https://indexed.vc/api/badge/company/inventia" alt="Inventia on Indexed.vc" width="260" height="76" /></a>